My fellow writers have written a lot about technical analysis here at The Motley Fool, and it's been entirely negative. I couldn't actually find a single article that endorsed the investment strategy. Here are just a couple of examples:
- Technical Analysis Is Stupid
- Tempted By Technical Analysis? It'll Cost You
- And this oldie but goodie: Is Technical Analysis Voodoo?
The reason Fools don't like technical analysis is because it bets that chart patterns will repeat. Which they actually do, sometimes.
And by sometimes, I mean completely randomly. As Anand Chokkavelu wrote in the first article linked above:
An October 2009 study by New Zealand's Massey University tested more than 5,000 technical analysis strategies in 49 different countries. The result? Not one strategy generated returns that aren't predicted by chance.
But I've found one chart pattern that I'm convinced will repeat itself, passing the test of time. I'm willing to bet on it, and I think you should too. (Anand is now my editor's boss, so I'm probably out of a job if I'm wrong.)
Introducing the "Little Trigger, Big Homecoming"
I named the chart pattern the Little Trigger, Big Homecoming, or LTBH for short, for reasons that will become apparent in a moment. It's a strong signal that you should buy.
You can see LTBH pattern forming on this chart in red.
Some people find it hard to draw the curve. Fortunately, if you put the Y-axis on a logarithmic scale, you can draw the LTBH pattern in a straight line rather than a curve. The price typically goes through the chart pattern a few times, as you would expect.
Here are a couple more charts that show the LTBH pattern -- all on the logarithmic Y-axis for easy charting.
Tell me more...
At this point, I hope you're either salivating at the opportunity to cash in on an easy investment, or you're laughing hysterically because you've already figured out that LTBH doesn't stand for Little Trigger, Big Homecoming, but Long Term Buy and Hold.
The first two charts above represent the S&P 500 index from 1950 onward. Recent bear markets in the early and late 2000s are easy to pick out. Earlier bear markets, such as 1980 and 1987, when the index fell 27.8% and 33.5% respectively, are harder to see because their effects are minimized as the index grows. If you hold for long enough, you can be unfortunate enough to buy at the top, and still come out OK.
The latter three charts are Johnson & Johnson (NYSE:JNJ), 3M (NYSE:MMM), and Procter & Gamble (NYSE:PG), respectively from 1970 onwards. All three include returns from dividends. If you reinvested those dividends, the slopes of the lines would be even steeper.
Healthcare conglomerate Johnson & Johnson has been around since 1886. Obviously, longevity doesn't ensure that a business model will continue to be successful, but Johnson & Johnson has been able to remain relevant by developing new medicines and medical devices as the industry has changed, while not being afraid to shed divisions that were no longer working. During the last couple of decades, Johnson & Johnson has been able to increase income faster than revenue by using its size to expand margins.
Similarly, 3M, which started in 1902, has been able to adapt as technology has changed. It's not selling as much videotape or floppy disks as it used to, but those sales have easily been replaced by new products, including 3M's move into healthcare and telemedicine. Like Johnson & Johnson, 3M has been able to expand margins, allowing earnings to grow faster than revenue.
Procter & Gamble, which started in 1837, isn't usually associated with innovation, but that's only because it's not in a high-tech industry. There's still innovation in laundry detergent and potato chip flavors that allows for continuing sales. Just as importantly, marketing and distribution, especially in developing countries, has helped Procter & Gamble continue to expand sales and earnings.
While I'm confident that the LTBH will work for an index such as the S&P 500 over the long term, that's not necessarily true for individual stocks. As the disclaimers point out, "past performance does not guarantee future results."
LTBH is ultimately more of a plan than a requirement. If the company changes enough that the investment thesis changes, investors shouldn't be afraid to sell.
The challenge for investors is to separate legitimate sell signals from general downturns. After all, there are plenty of places in the above charts for Johnson & Johnson, 3M, and Proctor & Gamble where the price drops below the red line; but selling there would miss out on long-term gains.
The key for investors is to stop worrying about the stock chart and start focusing on the underlying business. If that's still intact, it's probably worth taking the short-term lumps on the stock chart rather than trying to manipulate it by timing a jump out and back in.
Brian Orelli owns S&P500 index funds, but has no position in any individual stocks mentioned. The Motley Fool recommends Johnson & Johnson and Procter & Gamble. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
3 Dividend Stocks That Pay Out Over $8 Billion a Year
Can these huge companies keep the big dividend bucks flowing?
Johnson & Johnson Aims to Start 2018 Healthy
Investors have high hopes for the healthcare conglomerate.
Is Johnson & Johnson a Buy?
Is now a good time to invest in the healthcare titan's stock?